Cost-Utility Analysis of Recommended Ranibizumab Regimen for Age-Related Macular Degeneration in China

Xiaohua Ying(Fudan University), Jeffrey T. Chang(Tufts University), Shengjie Feng(Fudan University), Wenyu Wu(Fudan University)
Value in Health
October 26, 2014
Cited by 1


Related Papers